Heparin cofactor II: Discovery, properties, and role in controlling vascular homeostasis

Jill C. Rau, Jennifer W. Mitchell, Yolanda M Fortenberry, Frank C. Church

Research output: Contribution to journalArticle

Abstract

Heparin cofactor II (HCII) is a serine protease inhibitor (serpin) found in high concentrations in human plasma. Despite its discovery >30 years ago, its physiological function is still poorly understood. It is known to inhibit thrombin, the predominant coagulation protease, and HCII-thrombin complexes have been found in plasma, yet it is thought to contribute little to normal hemostasis. However, thrombin has several other physiological functions, and therefore many biological roles for HCII need consideration. The unique structure and mechanism of action of HCII have helped guide our understanding of HCII. In particular, HCII binds many glycosaminoglycans (GAGs) such as heparin and heparin sulfate as well as several different polyanions to enhance its inhibition of thrombin. Distinctly, HCII is able to use the GAG dermatan sulfate for accelerated thrombin inhibition. Dermatan sulfate is found in high concentrations in the walls of blood vessels as well as in placental tissue. This knowledge has led to research indicating that HCII may play a protective role in atherosclerosis and placental thrombosis. Additionally, pharmaceuticals are being developed that use the dermatan sulfate activation of HCII for anticoagulation. Although much research is still needed to fully understand HCII, this humble protein may have significant impact in our medical future. This article reviews the laboratory history, protein characteristics, structureactivity relationships, protease inhibition, physiological function, and medical relevance of HCII in hopes of regenerating interest in this sometimes forgotten serpin.

Original languageEnglish (US)
Pages (from-to)339-348
Number of pages10
JournalSeminars in Thrombosis and Hemostasis
Volume37
Issue number4
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Heparin Cofactor II
Blood Vessels
Homeostasis
Thrombin
Dermatan Sulfate
Serine Proteinase Inhibitors
Glycosaminoglycans
Heparin
Peptide Hydrolases
Hemostasis
Research
Sulfates
Atherosclerosis

Keywords

  • dermatan sulfate
  • heparin
  • Heparin cofactor II
  • serpin
  • thrombin

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Heparin cofactor II : Discovery, properties, and role in controlling vascular homeostasis. / Rau, Jill C.; Mitchell, Jennifer W.; Fortenberry, Yolanda M; Church, Frank C.

In: Seminars in Thrombosis and Hemostasis, Vol. 37, No. 4, 2011, p. 339-348.

Research output: Contribution to journalArticle

Rau, Jill C. ; Mitchell, Jennifer W. ; Fortenberry, Yolanda M ; Church, Frank C. / Heparin cofactor II : Discovery, properties, and role in controlling vascular homeostasis. In: Seminars in Thrombosis and Hemostasis. 2011 ; Vol. 37, No. 4. pp. 339-348.
@article{b7a7cd2297dc428a802439b633d14af3,
title = "Heparin cofactor II: Discovery, properties, and role in controlling vascular homeostasis",
abstract = "Heparin cofactor II (HCII) is a serine protease inhibitor (serpin) found in high concentrations in human plasma. Despite its discovery >30 years ago, its physiological function is still poorly understood. It is known to inhibit thrombin, the predominant coagulation protease, and HCII-thrombin complexes have been found in plasma, yet it is thought to contribute little to normal hemostasis. However, thrombin has several other physiological functions, and therefore many biological roles for HCII need consideration. The unique structure and mechanism of action of HCII have helped guide our understanding of HCII. In particular, HCII binds many glycosaminoglycans (GAGs) such as heparin and heparin sulfate as well as several different polyanions to enhance its inhibition of thrombin. Distinctly, HCII is able to use the GAG dermatan sulfate for accelerated thrombin inhibition. Dermatan sulfate is found in high concentrations in the walls of blood vessels as well as in placental tissue. This knowledge has led to research indicating that HCII may play a protective role in atherosclerosis and placental thrombosis. Additionally, pharmaceuticals are being developed that use the dermatan sulfate activation of HCII for anticoagulation. Although much research is still needed to fully understand HCII, this humble protein may have significant impact in our medical future. This article reviews the laboratory history, protein characteristics, structureactivity relationships, protease inhibition, physiological function, and medical relevance of HCII in hopes of regenerating interest in this sometimes forgotten serpin.",
keywords = "dermatan sulfate, heparin, Heparin cofactor II, serpin, thrombin",
author = "Rau, {Jill C.} and Mitchell, {Jennifer W.} and Fortenberry, {Yolanda M} and Church, {Frank C.}",
year = "2011",
doi = "10.1055/s-0031-1276582",
language = "English (US)",
volume = "37",
pages = "339--348",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - Heparin cofactor II

T2 - Discovery, properties, and role in controlling vascular homeostasis

AU - Rau, Jill C.

AU - Mitchell, Jennifer W.

AU - Fortenberry, Yolanda M

AU - Church, Frank C.

PY - 2011

Y1 - 2011

N2 - Heparin cofactor II (HCII) is a serine protease inhibitor (serpin) found in high concentrations in human plasma. Despite its discovery >30 years ago, its physiological function is still poorly understood. It is known to inhibit thrombin, the predominant coagulation protease, and HCII-thrombin complexes have been found in plasma, yet it is thought to contribute little to normal hemostasis. However, thrombin has several other physiological functions, and therefore many biological roles for HCII need consideration. The unique structure and mechanism of action of HCII have helped guide our understanding of HCII. In particular, HCII binds many glycosaminoglycans (GAGs) such as heparin and heparin sulfate as well as several different polyanions to enhance its inhibition of thrombin. Distinctly, HCII is able to use the GAG dermatan sulfate for accelerated thrombin inhibition. Dermatan sulfate is found in high concentrations in the walls of blood vessels as well as in placental tissue. This knowledge has led to research indicating that HCII may play a protective role in atherosclerosis and placental thrombosis. Additionally, pharmaceuticals are being developed that use the dermatan sulfate activation of HCII for anticoagulation. Although much research is still needed to fully understand HCII, this humble protein may have significant impact in our medical future. This article reviews the laboratory history, protein characteristics, structureactivity relationships, protease inhibition, physiological function, and medical relevance of HCII in hopes of regenerating interest in this sometimes forgotten serpin.

AB - Heparin cofactor II (HCII) is a serine protease inhibitor (serpin) found in high concentrations in human plasma. Despite its discovery >30 years ago, its physiological function is still poorly understood. It is known to inhibit thrombin, the predominant coagulation protease, and HCII-thrombin complexes have been found in plasma, yet it is thought to contribute little to normal hemostasis. However, thrombin has several other physiological functions, and therefore many biological roles for HCII need consideration. The unique structure and mechanism of action of HCII have helped guide our understanding of HCII. In particular, HCII binds many glycosaminoglycans (GAGs) such as heparin and heparin sulfate as well as several different polyanions to enhance its inhibition of thrombin. Distinctly, HCII is able to use the GAG dermatan sulfate for accelerated thrombin inhibition. Dermatan sulfate is found in high concentrations in the walls of blood vessels as well as in placental tissue. This knowledge has led to research indicating that HCII may play a protective role in atherosclerosis and placental thrombosis. Additionally, pharmaceuticals are being developed that use the dermatan sulfate activation of HCII for anticoagulation. Although much research is still needed to fully understand HCII, this humble protein may have significant impact in our medical future. This article reviews the laboratory history, protein characteristics, structureactivity relationships, protease inhibition, physiological function, and medical relevance of HCII in hopes of regenerating interest in this sometimes forgotten serpin.

KW - dermatan sulfate

KW - heparin

KW - Heparin cofactor II

KW - serpin

KW - thrombin

UR - http://www.scopus.com/inward/record.url?scp=79961089678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961089678&partnerID=8YFLogxK

U2 - 10.1055/s-0031-1276582

DO - 10.1055/s-0031-1276582

M3 - Article

C2 - 21805439

AN - SCOPUS:79961089678

VL - 37

SP - 339

EP - 348

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 4

ER -